Bausch Health vs Volkswagen: Founders, CEOs and History
Bausch Health was founded in 1994 by Eugene Melnyk, Milan Panic and is led by Thomas J. Appio. Volkswagen was founded in 1937 by Ferdinand Porsche and is led by Oliver Blume.
Company facts
Bausch Health
- Founded
- 1994
- Headquarters
- Laval, Quebec, Canada
- Current CEO
- Thomas J. Appio
- Employees
- 20,300
Volkswagen
- Founded
- 1937
- Headquarters
- Wolfsburg, Germany
- Current CEO
- Oliver Blume
- Employees
- 663,000
Founders
Bausch Health
Eugene Melnyk
Eugene Melnyk built Biovail into Canada's largest publicly traded pharmaceutical company, with revenue growing from about $19M in 1995 to roughly $1.07B in 2006.
Milan Panic
Milan Panic ran ICN Pharmaceuticals for four decades and made it known for the broad-spectrum antiviral ribavirin, sold as Virazole.
Volkswagen
Ferdinand Porsche
Ferdinand Porsche (1875-1951) was an Austrian-born automotive engineer who had worked for Lohner, Austro-Daimler and Daimler-Benz before opening his own design office in Stuttgart in 1931.
CEOs and their tenures
Bausch Health
- J. Michael Pearson2008–2016
Former Chief Executive Officer
Pearson, a former McKinsey director, became chief executive of Valeant Pharmaceuticals effective February 1, 2008 and ran the company through the September 2010 merger with Canada's Biovail until early May 2016.
Source - Joseph C. Papa2016–2022
Former Chief Executive Officer
Papa, previously chief executive of Perrigo, was named chairman and CEO in April 2016 and took over in early May 2016, inheriting about $30B of debt, an SEC investigation and congressional scrutiny of Valeant-era drug pricing.
Source - Thomas J. Appio2022–present
Chief Executive Officer
Appio became chief executive officer and a director in May 2022, succeeding Joseph Papa.
Source
Volkswagen
- Hermann Münch1946–1947
Chief Executive Officer
Early executive involved in the incredibly complex immediate post-war administration of the completely destroyed factory under British military control.
Source - Heinrich Nordhoff1948–1968
Chief Executive Officer
The absolute legendary post-war architect who took the ruins of the VW factory and transformed the Beetle into a massive, globally beloved cultural icon and economic miracle.
Source - Kurt Lotz1968–1971
Chief Executive Officer
Early post-war leader who began the critical process of diversifying VW's lineup beyond relying entirely on a single model (the Beetle).
Source - Rudolf Leiding1971–1975
Chief Executive Officer
Crucial CEO who managed the extremely difficult, highly risky transition away from the iconic but severely outdated Beetle toward modern, front-wheel-drive water-cooled cars (like the Golf).
Source - Toni Schmücker1975–1982
Chief Executive Officer
Guided the company through the severe financial crises of the 1970s, ensuring the successful launch and massive adoption of the original VW Golf.
Source - Carl Hahn1982–1993
Chief Executive Officer
As CEO in the 1980s, he executed the massive, highly strategic acquisitions of SEAT and Skoda, laying the foundation for VW's absolute dominance in Europe.
Source - Ferdinand Piëch1993–2002
Chief Executive Officer
As the legendary, absolutely ruthless patriarch (and grandson of Ferdinand Porsche), he transformed VW from a struggling mass-market brand into the most powerful automotive conglomerate on Earth.
Source - Bernd Pischetsrieder2002–2006
Chief Executive Officer
Serving as CEO from 2002 to 2006, he oversaw the incredibly complex integration of massive luxury brands like Bugatti and Bentley into the VW Group portfolio.
Source - Martin Winterkorn2007–2015
Chief Executive Officer
As the notoriously demanding, absolutely feared CEO, he oversaw massive global expansion but fostered a culture of absolute terror that led engineers to cheat rather than admit failure.
Source - Matthias Müller2015–2018
Chief Executive Officer
As CEO during the darkest period in modern VW history, he initiated the massive cultural purge of the toxic, highly secretive engineering culture that caused the cheating scandal.
Source - Herbert Diess2018–2022
Chief Executive Officer
Serving as CEO, he forcefully dragged the massive, highly bureaucratic legacy automaker into the Tesla era, though his abrasive style alienated the powerful Porsche-Piëch families.
Source - Oliver Blume2022–present
Chairman of the Board of Management
He also ran Porsche AG alongside the group role until Michael Leiters took over as Porsche CEO on January 1, 2026, leaving Blume focused on Volkswagen Group.
Source
Timeline: Bausch Health and Volkswagen side by side
1937Volkswagen
Volkswagen founded
Volkswagen was founded under the German Labour Front as part of a state-directed people's car program.
1945Volkswagen
Wolfsburg restarted
British military administration helped restart peacetime production at Wolfsburg after World War II.
1959Bausch Health
Milan Panic founds ICN Pharmaceuticals
Milan Panic, a Yugoslav immigrant to California, founded ICN Pharmaceuticals in 1959 and ran it for four decades. ICN is the predecessor of Valeant Pharmaceuticals and of today's Bausch Health.
1965Volkswagen
Audi foundation added
Volkswagen acquired Auto Union from Daimler-Benz, creating the foundation for modern Audi.
1974Volkswagen
Golf production begins
The Golf gave Volkswagen a modern front-engine, front-wheel-drive compact platform after the Beetle era.
1994Bausch Health
Biovail Corporation International formed in Canada
On March 29, 1994 Eugene Melnyk consolidated his Canadian drug-delivery business by amalgamating Trimel Corporation with its subsidiary to create Biovail Corporation International, the legal entity that files today as Bausch Health Companies Inc.
1998Volkswagen
Bentley, Bugatti and Lamborghini Acquired
Volkswagen bought Bentley, Bugatti and Lamborghini in 1998.
2003Bausch Health
ICN renames itself Valeant Pharmaceuticals
ICN Pharmaceuticals, then based in Costa Mesa, California, took the Valeant Pharmaceuticals name in November 2003 to distance itself from the governance fights of the Panic era.
2008Bausch Health
J. Michael Pearson becomes chief executive
Valeant appointed former McKinsey director J. Michael Pearson as chief executive effective February 1, 2008, succeeding Timothy C. Tyson. Pearson replaced internal research spending with debt-funded acquisitions of marketed drugs.
2010Bausch Health
Biovail and Valeant complete their merger
The merger of Biovail Corporation and Valeant Pharmaceuticals International closed on September 28, 2010. The combined company kept the Valeant name and Pearson as chief executive but was incorporated in Canada.
2011Bausch Health
Ortho Dermatologics bought from Johnson and Johnson
Valeant agreed to acquire the U.S. Ortho Dermatologics assets from Janssen Pharmaceuticals, a Johnson and Johnson company, for about $345M in cash, building the dermatology franchise.
2012Volkswagen
Porsche consolidated
Porsche became a controlled sport-luxury profit anchor within Volkswagen Group.
2013Bausch Health
Bausch + Lomb acquired for $8.7 billion
Valeant agreed in May 2013 to buy eye-health company Bausch + Lomb from Warburg Pincus for $8.7B in cash, adding contact lenses, lens care, ophthalmic drugs and surgical devices.
2015Bausch Health
Salix acquisition closes at about $11.1 billion
Valeant completed its tender offer for Salix Pharmaceuticals on April 1, 2015 at $173 per share, about $11.1B in equity value and roughly $15.8B including debt, gaining the Xifaxan franchise.
2015Bausch Health
Drug pricing and Philidor scandal breaks
Congressional investigators pressed Valeant over 525% and 212% increases on the heart drugs Isuprel and Nitropress, bought in February 2015, and over its undisclosed ties to the Philidor mail-order pharmacy.
2015Volkswagen
Matthias Müller becomes CEO
Matthias Müller became CEO of Volkswagen Aktiengesellschaft in 2015. Chief executive of Volkswagen Aktiengesellschaft from 2015 to 2018.
2015Volkswagen
Emissions Scandal
US regulators accused Volkswagen in September 2015 of fitting diesel cars with software that cheated emissions tests.
2016Bausch Health
Joseph Papa replaces Pearson as chief executive
Valeant named Perrigo chief executive Joseph C. Papa as chairman and CEO on April 25, 2016, and he took over in early May 2016 with about $30B of debt outstanding.
2017Bausch Health
Skincare brands and Dendreon sold to cut debt
Valeant sold the CeraVe, AcneFree and AMBI skincare brands to L'Oreal for about $1.3B and the Dendreon cancer unit to China's Sanpower Group for about $820M, using the proceeds to repay debt.
2018Bausch Health
Company renamed Bausch Health Companies Inc.
The name change from Valeant Pharmaceuticals International, Inc. to Bausch Health Companies Inc. was completed on July 13, 2018, and the shares began trading as BHC on the NYSE and TSX on July 16, 2018.
2018Volkswagen
Herbert Diess becomes CEO
Herbert Diess became CEO of Volkswagen Aktiengesellschaft in 2018. Chief executive of Volkswagen Aktiengesellschaft from 2018 to 2022.
2020Bausch Health
SEC settlement closes the Philidor accounting case
On July 31, 2020 Bausch Health agreed to pay a $45M civil penalty to settle SEC charges of improper revenue recognition and misleading disclosures tied to Philidor. Former chief executive J. Michael Pearson and two other executives also settled.
2022Bausch Health
Bausch + Lomb listed on the NYSE and TSX
Bausch + Lomb common stock began trading under the ticker BLCO on May 6, 2022, and a Bausch Health subsidiary sold 35,000,000 Bausch + Lomb shares in the offering. Bausch Health retained about 88% of the eye-health company and still consolidates it. Thomas J.
2022Volkswagen
Oliver Blume becomes chairman
Oliver Blume became chairman of Volkswagen Aktiengesellschaft in 2022. He also ran Porsche AG alongside the group role until Michael Leiters took over as Porsche CEO on January 1, 2026, leaving Blume focused on Volkswagen Group.
2024Volkswagen
Rivian software joint venture
Volkswagen and Rivian launched a software joint venture targeting next-generation electrical architecture.
2025Bausch Health
DURECT acquired and record annual revenue reported
Bausch Health closed the DURECT acquisition on September 11, 2025 for about $63M upfront, completed Solta Medical's Chinese aesthetics distribution purchase on December 1, 2025, and reported FY2025 revenue of $10.266B, up 7%, with net income attributable to Ba…
2025Volkswagen
Revenue reaches ~$364B (EUR321.9B)
Volkswagen reported ~$364 billion (EUR321.9 billion) in sales revenue, ~$10.1 billion (EUR8.9 billion) in operating result, and 8.984 million deliveries.
2026Bausch Health
RED-C trials miss endpoints and trigger a $1.4 billion charge
In January 2026 the two Phase 3 RED-C trials of amorphous-rifaximin soluble solid dispersion for primary prevention of hepatic encephalopathy missed their primary endpoints.
2026Bausch Health
Second-quarter 2026 revenue of $2.85 billion and raised guidance
Bausch Health reported second-quarter 2026 revenue of $2.85B, up 13%, net income attributable to Bausch Health of $258M and adjusted EBITDA of $1.075B, and raised its full-year 2026 revenue, adjusted EBITDA and cash flow guidance.
Acquisitions
Bausch Health
- DURECT Corporation2025$63M
- Shibo Zhenmei aesthetics distribution business2025Undisclosed
- Salix Pharmaceuticals2015$11.1B
- Bausch + Lomb Holdings2013$8.7B
- Ortho Dermatologics2011$345M
Volkswagen
- Porsche AG2012Undisclosed
- Bentley Motors1998Undisclosed
- Auto Union / Audi1965Undisclosed
Questions about Bausch Health vs Volkswagen
Who is the CEO of Bausch Health Companies Inc. and Volkswagen Aktiengesellschaft?
Bausch Health Companies Inc. is led by Thomas J. Appio and Volkswagen Aktiengesellschaft is led by Oliver Blume. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was Bausch Health Companies Inc. founded vs Volkswagen Aktiengesellschaft?
Volkswagen Aktiengesellschaft was founded in 1937 — 57 years before Bausch Health Companies Inc., which was founded in 1994. Volkswagen Aktiengesellschaft's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Bausch Health Companies Inc..
How many employees does Bausch Health Companies Inc. have compared to Volkswagen Aktiengesellschaft?
Bausch Health Companies Inc. employs approximately 20,300 people, while Volkswagen Aktiengesellschaft employs approximately 663,000. Volkswagen Aktiengesellschaft has the larger workforce at 663,000 employees, compared to Bausch Health Companies Inc.'s 20,300. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are Bausch Health Companies Inc. and Volkswagen Aktiengesellschaft headquartered?
Bausch Health Companies Inc. is headquartered in Canada and Volkswagen Aktiengesellschaft is headquartered in Germany. Their different home markets mean they may face different regulatory frameworks, tax regimes, and currency exposure.
Who founded Bausch Health Companies Inc. and Volkswagen Aktiengesellschaft?
Bausch Health Companies Inc. was founded by Eugene Melnyk, Milan Panic. Volkswagen Aktiengesellschaft was founded by Ferdinand Porsche.
Which company has a longer operating history — Bausch Health Companies Inc. or Volkswagen Aktiengesellschaft?
Volkswagen Aktiengesellschaft has been operating for approximately 89 years, making it the more established of the two companies. Bausch Health Companies Inc. has been in operation for around 32 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Bausch Health vs Volkswagen overview